Catalog No.
DHB65499
Description
Lifastuzumab vedotin is an ADC consisting of a NaPi2b-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer.
Species reactivity
Human
Clonality
Monoclonal
Target
NaPi2b
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
RG7599, DNIB0600A
Clone ID
Lifastuzumab vedotin
For research use only. Not for human or drug use.
